← Back to Clinical Trials
Recruiting NCT06397378

NCT06397378 Engaging College Students in Developing and Testing a Video-based Intervention for HPV Vaccination Promotion

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06397378
Status Recruiting
Phase
Sponsor Michigan State University
Condition N/A - Healthy Subjects
Study Type INTERVENTIONAL
Enrollment 123 participants
Start Date 2024-08-16
Primary Completion 2025-09-05

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 26 Years
Study Type INTERVENTIONAL
Interventions
short videos related to HPV and the HPV vaccineCDC HPV Fact Sheet

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 123 participants in total. It began in 2024-08-16 with a primary completion date of 2025-09-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

HPV vaccines offer hope against HPV-associated cancers for males and females; however, the rate of vaccination has not reached projected public health goals. This study will engage key stakeholders in the research process to co-design and pilot testing a video-based intervention addressing low HPV vaccination rates among college students The intervention and its approach have the potential to reduce health disparities in HPV-associated cancers in young adults via low-cost technology and timely intervention.

Eligibility Criteria

Inclusion Criteria: college students aged 18-26 never receive HPV vaccines able to understand English. Exclusion Criteria: not able to understand English younger than 18 or older than 26 years old have received HPV vaccines.

Contact & Investigator

Central Contact

ChengChing Hiya Liu, Ph. D.

✉ chengliu@msu.edu

📞 626-566-4835

Frequently Asked Questions

Who can join the NCT06397378 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 26 Years, studying N/A - Healthy Subjects. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06397378 currently recruiting?

Yes, NCT06397378 is actively recruiting participants. Contact the research team at chengliu@msu.edu for enrollment information.

Where is the NCT06397378 trial being conducted?

This trial is being conducted at East Lansing, United States.

Who is sponsoring the NCT06397378 clinical trial?

NCT06397378 is sponsored by Michigan State University. The trial plans to enroll 123 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology